Full-Time

QC Chemist I

Confirmed live in the last 24 hours

Becton Dickinson

Becton Dickinson

10,001+ employees

Global medical technology and diagnostics provider

Compensation Overview

$28.80 - $47.30/hr

Entry, Junior

San Diego, CA, USA

Minimum of 4 days in-office presence per week is required.

Category
Lab & Research
Life Sciences
Required Skills
Data Analysis
Requirements
  • BS degree in Chemistry, Biochemistry, Biology or relevant science discipline
  • Experience in a GMP environment preferred
  • Knowledge of biologics, small molecules, purification processes and experience in method development preferred
  • Basic understanding of chromatography and electrophoresis
  • Excellent written and verbal communication skills
  • Proficiency in Microsoft Office suite (Word, Excel, PowerPoint)
  • Ability to multitask efficiently
  • Must be able to work independently, as well as part of a team
Responsibilities
  • Characterize polymer size by GPC/SEC chromatography using established standard processes
  • Perform small scale dye labeling reactions according to established standard processes
  • Characterization of polymers by HPLC/FPLC using established standard processes
  • Optical characterization of the polymer dyes including measurement of absorbance and fluorescence emission spectra
  • May provide analysis and evaluation of material and products at all stages of development process
  • Participate in validation and measurement system analysis of various testing methods
  • Maintain equipment logs, calibration logs, and solvent/mobile phase preparation records
  • Test products for long-term stability under various conditions
  • Provide timely and high-quality data reports that document test results
  • Interface, maintain, and populate data and results in specified database(s)
  • Promote a safe work environment
  • May provide recommendations on maintaining the safety of the work environment
  • Participates in Environmental Health and Safety programs
  • Addresses corrective actions whenever a hazard is identified
  • Notifies supervisor of all observed hazardous conditions or unsafe work practices
  • Other responsibilities or projects as assigned by reporting manager
Desired Qualifications
  • Laboratory experience including HPLC, GC, ELFA, spectroscopy, plate reader, etc.
  • Experience with protein characterization methods such as Western blots, SDS PAGE, mass spec, etc.
  • Knowledge of FDA and cGMP guidelines
  • Experience in a GLP or GMP facility

BD (Becton, Dickinson and Company) is a global medical technology company that enhances health through improved medical discovery, diagnostics, and care delivery. It serves hospitals, laboratories, and healthcare providers worldwide. BD operates in three main areas: BD Medical, which focuses on medication management and delivery; BD Life Sciences, which provides safe collection and transport products for diagnostic specimens; and BD Interventional, which offers devices for minimally invasive surgeries. The company generates revenue by selling medical devices, laboratory equipment, and diagnostic products. BD stands out from competitors by emphasizing innovation, quality, and customer service, with the goal of improving patient outcomes, reducing healthcare costs, and increasing safety and efficiency in healthcare.

Company Size

10,001+

Company Stage

IPO

Headquarters

Franklin Lakes, New Jersey

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • BD's focus on digital health aligns with telemedicine and remote monitoring trends.
  • BD's investment in syringe manufacturing supports pandemic preparedness.
  • BD's acquisition of Tissuemed enhances its minimally invasive surgical solutions.

What critics are saying

  • Increased competition from companies like Abbott and Roche in digital health.
  • Potential regulatory challenges with new acquisitions like MedKeeper and Scanwell Health.
  • Supply chain vulnerabilities in sourcing raw materials for syringe manufacturing.

What makes Becton Dickinson unique

  • BD's acquisition of MedKeeper enhances its cloud-based pharmacy management capabilities.
  • BD's investment in syringe manufacturing aligns with global vaccination trends.
  • BD's acquisition of Cytognos expands its post-treatment monitoring capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Tuition Reimbursement

Company News

Slater Sentinel
Jan 4th, 2024
Affinity Wealth Management LLC Invests $2.18 Million in Becton, Dickinson and Company (NYSE:BDX)

Affinity Wealth Management LLC purchased a new stake in shares of Becton, Dickinson and Company (NYSE:BDX – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 8,443 shares of the medical instruments supplier’s stock, valued at approximately $2,183,000. Other […]

PR Newswire
Jul 28th, 2022
BD Acquires MedKeeper to Offer Cloud-based, Connected Pharmacy Software

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired MedKeeper, a...

ROI-NJ
Jul 28th, 2022
Bd Acquires Medkeeper To Offer Cloud-Based, Connected Pharmacy Software

BD on Thursday said it acquired MedKeeper, a provider of modern, cloud-based pharmacy management applications. The acquisition adds to the Franklin Lakes-based company’s recent growth in high-technology pharmacy solutions and further accelerates its commitment to smart, connected care

PR Newswire
Feb 9th, 2022
Day Zero Diagnostics Announces Completion of $21M Financing

/PRNewswire/ -- Day Zero Diagnostics, Inc., an infectious disease diagnostics company harnessing the power of whole-genome sequencing and machine learning to...

PR Newswire
Feb 1st, 2022
BD Expands from Cancer Discovery and Diagnosis into Post-Treatment Monitoring with Acquisition of Cytognos from Vitro S.A.

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition...